HaugenBR, AlexanderEK, BibleKC, DohertyGM, MandelSJ, NikiforovYE, PaciniF, RandolphGW, SawkaAM, SchlumbergerM, SchuffKG, ShermanSI, SosaJA, StewardDL, TuttleRM, WartofskyL. 2016. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 26:1–133.
2.
GharibH, PapiniE, GarberJR, DuickDS, HarrellRM, HegedüsL, PaschkeR, ValcaviR, VittiP. 2016. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules—2016 update. Endocr Pract, 22 (supplementum 1):1–60.
HegedüsL. 2004. Clinical practice. The thyroid nodule. N Engl J Med, 351:1764–1771.
5.
TuttleRM, ZhangL, ShahaA. 2018. A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management. Expert Rev Endocrinol Metab, 13:77–85.
6.
BernardiS, GiudiciF, CesareoR, AntonelliG, CavallaroM, DeandreaM, GiustiM, MormileA, NegroR, PalermoA, PapiniE, PasqualiniV, RaggiuntiB, RossiD, SconfienzaLM, SolbiatiL, SpieziaS, TinaD, VeraL, StaculF, MauriG. 2020. Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian minimally invasive treatments of the thyroid group. Thyroid, 30:1759–1770.
7.
ChoSJ, BaekSM, LimHK, LeeKD, SonJM, BaekJH. 2020. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid, 30:1745–1751.
8.
TengDK, LiWH, DuJR, WangH, YangDY, WuXL. 2020. Effects of microwave ablation on papillary thyroid microcarcinoma: a five-year follow-up report. Thyroid, 30:1752–1758.
9.
PaschkeR, HegedüsL, AlexanderE, ValcaviR, PapiniE, GharibH. 2011. Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol, 7:354–361.
FeldkampJ, GrünwaldF, LusterM, LorenzK, VorländerC, FührerD. 2020. Non-surgical and non-radioiodine techniques for ablation of benign thyroid nodules: consensus statement and recommendation. Exp Clin Endocrinol Diabetes, 7:1075–2025.
12.
PapiniE, MonpeyssenH, FrasoldatiA, HegedüsL. 2020. European Thyroid Association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules. Eur Thyroid J, 94:172–185.
13.
HegedüsL, FrasoldatiA, NegroR, PapiniE. 2020. European Thyroid Association survey on use of minimally invasive techniques for thyroid nodules. Eur Thyroid J, 94:194–204.
14.
WattT, CramonP, HegedüsL, BjornerJB, BonnemaSJ, Rasmussen ÅK, Feldt-RasmussenU, GroenvoldM. 2014. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab, 99:3708–3717.
15.
HaEJ, BaekJH, KimKW, PyoJ, LeeJH, BaekSH, DøssingH, HegedüsL. 2015. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab, 100:1903–1911.
16.
TrimboliP, CastellanaM, SconfienzaLM, ViriliC, PescatoriLC, CesareoR, GiorginoF, NegroR, GiovanellaL, MauriG. 2020. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine, 67:35–43.
17.
DeandreaM, GarinoF, AlbertoM, GarberoglioR, RossettoR, BonelliN, SpieziaS, De SantisM, MontiS, DeianaMG, VincenzoT, CuginiC, El DalatiG, LimonePP. 2019. Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study. Eur J Endocrinol, 180:79–87.
18.
DøssingH, BennedbaekFN, BonnemaSJ, GrupeP, HegedüsL. 2007. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol, 157:95–100.
19.
ZhaoQ, TianG, KongD, JiangT. 2016. Meta-analysis of radiofrequency ablation for treating the local recurrence of thyroid cancers. J Endocrinol Invest, 39:909–916.
20.
ChoSJ, BaekJH, ChungSR, ChoiYJ, LeeJH. 2019. Thermal ablation for small papillary thyroid cancer: a systematic review. Thyroid, 29:1774–1783.
21.
ItoY, MiyauchiA. 2019. Active surveillance as first-line management of papillary microcarcinoma. Annu Rev Med, 70:369–379.
22.
ItoY, MiyauchiA, OdaH. 2018. Low-risk papillary microcarcinoma of the thyroid: a review of active surveillance trials. Eur J Surg Oncol, 44: 307–315.
23.
DaviesL, HendricksonCD, HansonGS. 2017. Experience of US patients who self-identify as having an overdiagnosed thyroid cancer: a qualitative analysis. JAMA Otolaryngol Head Neck Surg, 143:663–669.
24.
D'AgostinoTA, ShukE, MaloneyEK, ZeurenR, TuttleRM, BylundCL. 2018. Treatment decision making in early-stage papillary thyroid cancer. Psychooncology, 27:61–68.
25.
DaviesL, RomanBR, FukushimaM, ItoY, MiyauchiA. 2019. Patient experience of thyroid cancer active surveillance in Japan. JAMA Otolaryngol Head Neck Surg, 145:363–370.
26.
BresnerL, BanachR, RodinG, ThabaneL, EzzatS, SawkaAM. 2015. Cancer-related worry in Canadian thyroid cancer survivors. J Clin Endocrinol Metab, 100:977–985.
27.
BritoJP, MoonJH, ZeurenR, KongSH, KimYG, Iniguez-ArizaNM, ChoiJY, LeeKE, KimJH, HargravesI, BernetV, MontoriVM, ParkYJ, TuttleRM. 2018. Thyroid cancer treatment choice: a pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options. Thyroid, 28:1325–1331.
28.
HedmanC, DjärvT, StrangP, LundgrenCI. 2018. Fear of recurrence and view of life affect health-related quality of life in patients with differentiated thyroid carcinoma: a prospective swedish population-based study. Thyroid, 28:1609–1617.
